Prostatic Carcinoma

Publisher Website
Google Scholar
Abstract
EACH year there are 42,000 new cases of prostatic carcinoma in the United States,1 and with 17,000 deaths per year, it is the second leading cause of cancer deaths among American men.2 Despite these alarming statistics, it can be calculated that 30 per cent, or roughly 12,000, of the new cases are potentially curable when first discovered.* But it seems that treatment designed to cure patients of this disease is being provided to only a fraction of the potentially curable ones. Consider that one of the most active groups in the country engaged in urologic surgery and oncology attempts cure . . .